**Core Concept**
The question is testing the student's knowledge of pharmacological management of acute gout. Acute gout is a painful form of inflammatory arthritis caused by deposition of monosodium urate crystals in joints. The goal of treatment is to reduce inflammation and alleviate pain.

**Why the Correct Answer is Right**
The correct answer is Colchicine, which is a microtubule inhibitor that reduces inflammation by inhibiting the migration and phagocytosis of neutrophils. Colchicine acts by binding to tubulin and preventing microtubule polymerization, which is essential for neutrophil function. This leads to a decrease in neutrophil accumulation in the joint and subsequent reduction in inflammation.

**Why Each Wrong Option is Incorrect**
**Option A:** NSAIDs are not the first-line treatment for acute gout, although they may be used as an adjunct to colchicine or other treatments.
**Option B:** Corticosteroids can be used in the treatment of acute gout, but they are not the preferred initial treatment.
**Option C:** Allopurinol is a xanthine oxidase inhibitor used for the prophylaxis of gout, but it is not used for the treatment of acute gout attacks.

**Clinical Pearl / High-Yield Fact**
Colchicine is a classic example of a drug that is effective in the treatment of acute gout, but it is poorly absorbed orally and has a narrow therapeutic index, making it a challenging drug to use.

**Correct Answer: D. Colchicine**